GT

G1 Therapeutics IncNASDAQ GTHX Stock Report

Last reporting period 30 Jun, 2024

Updated 17 Sep, 2024

Last price

Market cap $B

0.377

Micro

Exchange

XNAS - Nasdaq

View Full Company Analysis

Return on equity ROE

-137 %

Last period ROE


What is ROE ?

The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.

What is ROE ?

The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.

What is ROE of G1 ?

G1`s ROE for the last twelve months ended 2024-06-30 is -137 %

View Full Company Analysis